Aberforth Smaller Trust (LSE:ASL) Research & Development: £0.00 Mil (TTM As of Dec. 2025)


LSE:ASL Aberforth Smaller Companies Trust PLC LSE:ASL
57 GF Score
Price £16.16
GF Value £13.48
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Aberforth Smaller Trust Research & Development?

Aberforth Smaller Trust LSE:ASL +0.50% 57 Research & Development is £0.00 Mil as of Dec. 2025. GuruFocus rates LSE:ASL with a GF Score™ of 57/100 and a GF Value™ of £13.48 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Aberforth Smaller Trust's Research & Development for the six months ended in Dec. 2025 was £0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was £0.00 Mil.

Aberforth Smaller Trust  (LSE:ASL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aberforth Smaller Trust Research & Development Related Terms

Aberforth Smaller Trust Research & Development Historical Data

* Premium members only.

The historical data trend for Aberforth Smaller Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aberforth Smaller Trust Research & Development Chart

Aberforth Smaller Trust Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Aberforth Smaller Trust Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:ASL
57GF Score
Aberforth Smaller Companies Trust PLC LSE:ASL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aberforth Smaller Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.00 Mil mean?
Aberforth Smaller Trust (LSE:ASL) has a Research & Development of £0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Aberforth Smaller Trust and its competitors.
Is Aberforth Smaller Trust's Research & Development too high?
Aberforth Smaller Trust's current Research & Development is £0.00 Mil. Overall, Aberforth Smaller Trust has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aberforth Smaller Trust's Research & Development compare to BLK and BX?
Aberforth Smaller Trust's Research & Development of £0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Aberforth Smaller Trust and its competitors. Aberforth Smaller Trust's current Research & Development is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aberforth Smaller Trust stock overvalued right now?
Based on GuruFocus' analysis, Aberforth Smaller Trust (LSE:ASL) is currently considered Modestly Overvalued. The stock's GF Value™ is £13.48, compared to a current price of £16.16 — trading 19.9% above its estimated fair value. The current Research & Development is £0.00 Mil. Aberforth Smaller Trust's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Aberforth Smaller Trust (LSE:ASL), the current Research & Development is £0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aberforth Smaller Trust (LSE:ASL) Overvalued in 2026?

Based on GuruFocus' analysis, Aberforth Smaller Trust stock appears to be overvalued. The current stock price of £16.16 is trading 19.9% above its estimated GF Value™ of £13.48. GuruFocus considers Aberforth Smaller Trust to be Modestly Overvalued.

Key valuation signals for LSE:ASL:

  • Research & Development: £0.00 Mil
  • GF Value™: £13.48 vs. price of £16.16 (19.9% above fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the LSE:ASL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aberforth Smaller Trust Business Description

Address 14 Melville Street, Edinburgh, GBR, EH3 7NS
Aberforth Smaller Companies Trust PLC is a UK based closed-ended investment trust. Its objective is to achieve a net asset value total return (with dividends reinvested) greater than that of the Numis Smaller Companies Index (excluding Investment Companies) over the long term. The Company also aims to achieve its objective by investing in small United Kingdom quoted companies. It invests in various sectors, such as technology, telecommunications, health care, financials, real estate, consumer discretionary, consumer staples, industrials, basic materials and energy.
57GF Score

Get the complete analysis for LSE:ASL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£16.16
Price
£13.48
GF Value